Elicio Therapeutics (ELTX) announced the appointment of Marc Wolfgang, M.S. as Chief Technology Officer. He most recently served as Senior Vice President of Technical Development and Operations at Sail Biomedicines.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELTX:
- Elicio Therapeutics Reports Q3 2025 Financial Results
- Elicio Therapeutics files to sell 103,225 shares of common stock for holders
- Elicio Therapeutics announces additional data from Phase 2 AMPLIFY-7P trial
- Elicio announces preliminary analysis from Phase 2 AMPLIFY-7P trial
- Elicio Therapeutics announces investigator-initiated Phase 1 trial of ELI-002 7P